Literature DB >> 1713128

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene.

E P Sandgren1, R D Palmiter, J L Heckel, C C Daugherty, R L Brinster, J L Degen.   

Abstract

We previously demonstrated that expression of an albumin-urokinase-type plasminogen activator (Alb-uPA) fusion construct in transgenic mice resulted in elevated plasma uPA concentration, hypofibrinogenemia, and neonatal hemorrhaging. Two lines of Alb-uPA mice were established in which only one half of the transgenic pups died at birth; surprisingly, plasma uPA concentrations in survivors gradually returned to normal by 2 months of age. The basis for this phenomenon is DNA rearrangement within hepatocytes that affects the transgene tandem array and abolishes transgene expression. Transgene-deficient cells selectively proliferate relative to surrounding liver, and this process culminates in replacement of the entire liver by clonal hepatic nodules derived from transgene-deficient progenitor cells. In some cases as few as two nodules can reconstitute over 90% of liver mass, highlighting the remarkable regenerative capacity of individual liver cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713128     DOI: 10.1016/0092-8674(91)90615-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  107 in total

1.  The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion.

Authors:  K Overturf; M Al-Dhalimy; M Finegold; M Grompe
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.

Authors:  K M Braun; E P Sandgren
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 3.  Animal models for studying hepatitis C and alcohol effects on liver.

Authors:  David F Mercer
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

4.  Generation of functional hepatic cells from pluripotent stem cells.

Authors:  Songyan Han; Alice Bourdon; Wissam Hamou; Noelle Dziedzic; Orit Goldman; Valerie Gouon-Evans
Journal:  J Stem Cell Res Ther       Date:  2012-08-15

5.  Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors:  Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

Review 6.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

7.  Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus.

Authors:  K W Dobie; M Lee; J A Fantes; E Graham; A J Clark; A Springbett; R Lathe; M McClenaghan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

8.  Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.

Authors:  T Toyonaga; O Hino; S Sugai; S Wakasugi; K Abe; M Shichiri; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.

Authors:  Stephanie A K Angarita; Brian Truong; Suhail Khoja; Matthew Nitzahn; Abha K Rajbhandari; Irina Zhuravka; Sergio Duarte; Michael G Lin; Alex K Lam; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2018-04-21       Impact factor: 4.797

10.  CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy.

Authors:  L E Greenbaum; W Li; D E Cressman; Y Peng; G Ciliberto; V Poli; R Taub
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.